Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering ; volume:13 ; number:1 ; day:10 ; month:5 ; year:2021 ; pages:1-3 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (10.5.2021), 1-3, 12.2021
- Urheber
-
Cummings, Jeffrey
Aisen, Paul
Lemere, Cynthia
Atri, Alireza
Sabbagh, Marwan
Salloway, Stephen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00838-z
- URN
-
urn:nbn:de:101:1-2021091120580410257277
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cummings, Jeffrey
- Aisen, Paul
- Lemere, Cynthia
- Atri, Alireza
- Sabbagh, Marwan
- Salloway, Stephen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Selective amyloid-β lowering agents
Critical Appraisal of Amyloid Lowering Agents in AD
Atypical brain asymmetry in autism - a candidate for clinically meaningful stratification
Atypical brain asymmetry in autism - a candidate for clinically meaningful stratification
Assessing clinically meaningful hypercoagulability after COVID-19 Vaccination: a longitudinal study
Clinically Meaningful Change for Physical Performance: Perspectives of the ICFSR Task Force
Palmitoylethanolamide and Luteolin for Postinfectious Olfactory Disorders: How Clinically Meaningful Is Its Effect?
Amyloid-PET imaging predicts functional decline in clinically normal individuals
Amyloid-Precursor-Protein-lowering small molecules for disease modifying therapy of Alzheimer's disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold
Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold
Selective amyloid-β lowering agents
Critical Appraisal of Amyloid Lowering Agents in AD
Atypical brain asymmetry in autism - a candidate for clinically meaningful stratification
Atypical brain asymmetry in autism - a candidate for clinically meaningful stratification
Assessing clinically meaningful hypercoagulability after COVID-19 Vaccination: a longitudinal study
Clinically Meaningful Change for Physical Performance: Perspectives of the ICFSR Task Force
Palmitoylethanolamide and Luteolin for Postinfectious Olfactory Disorders: How Clinically Meaningful Is Its Effect?
Amyloid-PET imaging predicts functional decline in clinically normal individuals
Amyloid-Precursor-Protein-lowering small molecules for disease modifying therapy of Alzheimer's disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold
Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold
Selective amyloid-β lowering agents
Critical Appraisal of Amyloid Lowering Agents in AD
Atypical brain asymmetry in autism - a candidate for clinically meaningful stratification
Atypical brain asymmetry in autism - a candidate for clinically meaningful stratification
Assessing clinically meaningful hypercoagulability after COVID-19 Vaccination: a longitudinal study
Clinically Meaningful Change for Physical Performance: Perspectives of the ICFSR Task Force
Palmitoylethanolamide and Luteolin for Postinfectious Olfactory Disorders: How Clinically Meaningful Is Its Effect?
Amyloid-PET imaging predicts functional decline in clinically normal individuals
Amyloid-Precursor-Protein-lowering small molecules for disease modifying therapy of Alzheimer's disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold